Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Tufia C Haddad"'
Autor:
Nathan P Young, Jennifer L Ridgeway, Tufia C Haddad, Sarah B Harper, Lindsey M Philpot, Laura A Christopherson, Samantha M McColley, Sarah A Phillips, Julie K Brown, Kelly S Zimmerman, Jon O Ebbert
Publikováno v:
JMIR Formative Research, Vol 7, p e48372 (2023)
BackgroundMigraine is a common and major cause of disability, poor quality of life, and high health care use. Access to evidence-based migraine care is limited and projected to worsen. Novel mobile health app–based tools may effectively deliver mig
Externí odkaz:
https://doaj.org/article/0a51f93c0e2c49e688ab47410fe9197b
Autor:
Tufia C Haddad, Karla C Maita, Jonathan W Inselman, Francisco R Avila, Ricardo A Torres-Guzman, Jordan D Coffey, Laura A Christopherson, Angela M Leuenberger, Sarah J Bell, Dominick F Pahl, John P Garcia, Lukas Manka, Antonio J Forte, Michael J Maniaci
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e44528 (2023)
BackgroundRemote patient monitoring (RPM) is an option for continuously managing the care of patients in the comfort of their homes or locations outside hospitals and clinics. Patient engagement with RPM programs is essential for achieving successful
Externí odkaz:
https://doaj.org/article/184a88e6c6c6491fac5aaf2c404ef094
Autor:
Melinda L. Telli, Sara M. Tolaney, Geoffrey I. Shapiro, Mark Middleton, Simon R. Lord, Hendrik Tobias Arkenau, Andrew Tutt, Vandana Abramson, Emma Dean, Tufia C. Haddad, Robert Wesolowski, Jordi Ferrer-Playan, Thomas Goddemeier, Thomas Grombacher, Jennifer Dong, Patricia Fleuranceau-Morel, Ivan Diaz-Padilla, Ruth Plummer
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Platinum derivatives are commonly used for the treatment of patients with metastatic triple-negative breast cancer (TNBC). However, resistance often develops, leading to treatment failure. This expansion cohort (part C2) of the previously re
Externí odkaz:
https://doaj.org/article/43046c012d264b0db69478944d5e396f
Autor:
Jordan D. Coffey, Laura A. Christopherson, Amy E. Glasgow, Kristina K. Pearson, Julie K. Brown, Shelby R. Gathje, Lindsey R. Sangaralingham, Eva M. Carmona Porquera, Abinash Virk, Robert Orenstein, Leigh L. Speicher, Dennis M. Bierle, Ravindra Ganesh, Debra L. Cox, R. Nicole Blegen, Tufia C. Haddad
Publikováno v:
npj Digital Medicine, Vol 4, Iss 1, Pp 1-11 (2021)
Abstract Established technology, operational infrastructure, and nursing resources were leveraged to develop a remote patient monitoring (RPM) program for ambulatory management of patients with COVID-19. The program included two care-delivery models
Externí odkaz:
https://doaj.org/article/863419a993a147c7ade739c1b9dfaa0f
Autor:
Ravindra Ganesh, MD, MBBS, Bradley R. Salonen, MD, M. Nadir Bhuiyan, MD, Dennis M. Bierle, MD, Darcie Moehnke, RN, Tufia C. Haddad, MD, Aaron J. Tande, MD, John Wilson, MD, Ryan T. Hurt, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 118-126 (2021)
Objective: To study the impact of a 60-day pilot of an innovative virtual-care model using general internal medicine physicians and nurses to respond rapidly to more than 1200 coronavirus disease-2019 (COVID-19)-positive nasopharyngeal polymerase cha
Externí odkaz:
https://doaj.org/article/4eb64fffa5344675abce2d512248926b
Autor:
Amye J. Tevaarwerk, Elizabeth S. Harlos, Matthew J. Maurer, Heather L. VanBebber, Eli J. Misel, Sacha A. Nelson, Sara J. Holton, Abigail L. Stockham, Tufia C. Haddad, Steven R. Alberts, Robert R. McWilliams, Sumithra J. Mandrekar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:QIM23-138
Autor:
Tufia C. Haddad, Jordan D. Coffey, Yihong Deng, Amy E. Glasgow, Laura A. Christopherson, Lindsey R. Sangaralingham, Sarah J. Bell, Vishal P. Shah, Joshua C. Pritchett, Robert Orenstein, Leigh L. Speicher, Michael J. Maniaci, Ravindra Ganesh, Bijan J. Borah
Publikováno v:
Mayo Clinic Proceedings. 97:2215-2225
To evaluate care utilization, cost, and mortality among high-risk patients enrolled in a coronavirus disease 2019 (COVID-19) remote patient monitoring (RPM) program.This retrospective analysis included patients diagnosed with COVID-19 at risk for sev
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast
Autor:
Utsav Joshi, Pravash Budhathoki, Suman Gaire, Sumeet K. Yadav, Anish Shah, Anurag Adhikari, Grace Choong, Rima Couzi, Karthik Giridhar, Roberto Leon-Ferre, Judy C. Boughey, Tina J. Hieken, Robert Mutter, Kathryn J. Ruddy, Tufia C. Haddad, Matthew P. Goetz, Fergus J. Couch, Siddhartha Yadav
Publikováno v:
Breast Cancer Research and Treatment.
Purpose: Triple-negative invasive lobular carcinoma (TN-ILC) of breast cancer is a rare disease and the clinical outcomes and prognostic factors are not well-defined. Methods: Women with stage I-III TN-ILC or triple-negative invasive ductal carcinoma
Autor:
Nathan P. Young, Jennifer L. Ridgeway, Tufia C. Haddad, Sarah B. Harper, Lindsey M. Philpot, Laura A. Christopherson, Samantha M McColley, Sarah A. Phillips, Julie K. Brown, Kelly S. Zimmerman, Jon O. Ebbert
BACKGROUND Migraine is a common major cause of disability, poor quality of life, and high health care utilization. Access to evidence-based migraine care is limited and projected to worsen. Novel health care delivery models including mHealth app-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb772b592d0bc3a9d71b0885650a7873
https://doi.org/10.2196/preprints.48372
https://doi.org/10.2196/preprints.48372
Autor:
Jennifer R. Diamond, E. Jane Leonard, Rachel Neuwirth, Chirag Patel, Kevin J. Galinsky, Brittany Bahamon, Sylvie Vincent, Elizabeth Tan-Chiu, Hugues Bourgeois, Alain Lortholary, Michael Danso, Jean-Luc Canon, Ahmad Awada, Frederic Forget, Tufia C. Haddad, Paula Silverman, Mohamad A. Salkeni, David A. Potter, Bora Lim
Purpose:This open-label, multicenter, phase IB/II study evaluated sapanisertib, a dual inhibitor of mTOR kinase complexes 1/2, plus exemestane or fulvestrant in postmenopausal women with hormone receptor–positive (HR+)/HER2-negative (HER2−) advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a526ebea64aa340013a9808ee8cfc04
https://doi.org/10.1158/1078-0432.c.6530012.v1
https://doi.org/10.1158/1078-0432.c.6530012.v1